| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |